Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-26-052742

CEO & President bought 38,000 shares at $0.14 ($5,130)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Purchase : show line 1 in the form +38,000 $0.14 $5,130 366,095 D
Open-market purchases · 38,000 sh · avg $0.14 · $5,130
Loading xslF345X06/ownership.xml…